Portland Trail Blazers Preparing for Potential Deni Avdija Departure
Portland, Oregon, is reportedly bracing for the possibility that Israeli basketball star Deni Avdija might leave the Trail Blazers when his current contract expires. American media outlets are closely following Avdija's situation, with speculation mounting that his next contract, expected to be significantly larger, may not be with Portland. Fans have been advised to prepare for this scenario, as Avdija is projected to become an unrestricted free agent at the end of the 2027-2028 NBA season.
Avdija's current contract is described as highly favorable for the team, saving them millions. However, it also presents limitations under NBA regulations regarding contract extensions and the amount the team can offer. Even with a potential upgrade, the sum Portland could offer is anticipated to be substantially less than Avdija's market value. The option for Portland to renegotiate and extend his contract is deemed impractical, as it would likely require trading high-salaried players, potentially hindering the team's competitiveness. Given Avdija's competitive nature, such a move is considered unlikely to be logical from his perspective.
There is no certainty that Avdija will remain with Portland after his current deal concludes. The Trail Blazers' management is apparently preparing for a potential team reset without him, should he sign elsewhere. The two years remaining on his contract create a period of uncertainty surrounding his future with the team, with anticipation expected to build as the decision point approaches.
Currently, the recommended strategy for the club is to maximize their competitive window while Avdija is on his current, cost-effective contract. Simultaneously, the team aims to maintain flexibility for the period beyond 2028.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.